Expression of the type 1 cannabinoid receptor (CB1R) in CCK-immunoreactive axon terminals in the basolateral amygdala of the rhesus monkey (Macaca mulatta)

This publication has 24 references indexed in Scilit:

• Interneurons in the basolateral amygdala
  Neuropharmacology, 2011
• Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus
  Proceedings of the National Academy of Sciences, 2011
• PET Imaging Studies in Rhesus Monkey with the Cannabinoid-1 (CB1) Receptor Ligand [11C]CB-119
  Molecular Imaging and Biology, 2009
• Functional Interactions between Endocannabinoid and CCK Neurotransmitter Systems May Be Critical for Extinction Learning
  Neuropsychopharmacology, 2008
• Postsynaptic mechanisms underlying responsiveness of amygdaloid neurons to cholecystokinin are mediated by a transient receptor potential-like current
  Molecular and Cellular Neuroscience, 2007
• Subcellular Arrangement of Molecules for 2-Arachidonoyl-Glycerol-Mediated Retrograde Signaling and Its Physiological Contribution to Synaptic Modulation in the Striatum
  The Journal of Neuroscience, 2007
• Activation of the Cannabinoid Receptor Type 1 Decreases Glutamatergic and GABAergic Synaptic Transmission in the Lateral Amygdala of the Mouse
  Learning & Memory, 2003
• Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
  Neuroscience, 1997
• Cannabinoid receptor binding and messenger RNA expression in human brain: An in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains
  Neuroscience, 1994
• Cholecystokinin Tetrapeptide Induces Panic-like Attacks in Healthy Volunteers
  Archives of General Psychiatry, 1989